Indication
Superficial Basal Cell Carcinoma
5 clinical trials
11 products
Clinical trial
An Exploratory Study to Evaluate the Safety and Efficacy of AIV001 Intradermally Administered in Subjects With Biopsy-confirmed Basal Cell CarcinomaStatus: Completed, Estimated PCD: 2023-06-20
Clinical trial
A Randomized, Double Blind, Vehicle-controlled Multicenter Phase III Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).Status: Active (not recruiting), Estimated PCD: 2024-03-19
Product
Photodynamic therapy (PDT)Product
AIV001Product
Photodynamic therapyProduct
Placebo Photodynamic TherapyClinical trial
Jet-Injection Assisted Photodynamic Therapy for Basal Cell CarcinomaStatus: Active (not recruiting), Estimated PCD: 2024-09-09
Product
ALAClinical trial
Combination of 5-Fluorouracil and Calcipotriene in the Treatment of Superficial Basal Cell Carcinomas and Squamous Cell Carcinomas in SituStatus: Recruiting, Estimated PCD: 2025-06-01
Product
5-FluorouracilClinical trial
A Phase 2, Single-Arm, Open-Label, Single Center Study to Assess Efficacy and Safety of Tirbanibulin Ointment 1% in Adult Subjects With Superficial Basal Cell Carcinoma (sBCC) on the Neck, Trunk, or Extremities (Excluding Axilla, Anogenital, and Face/Scalp)Status: Recruiting, Estimated PCD: 2023-12-10
Product
Tirbanibulin